Related Experiment Videos
[Analytical choices for biological tests in thrombotic pathology]
1Service d'hématologie biologique A, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75908 Paris, France. martine.aiach@egp.ap-hop-paris.fr
Gynecologie, Obstetrique & Fertilite
|August 30, 2002
Summary
Understanding genetic and environmental risk factors helps identify patients prone to recurrent thromboembolism (TE). Laboratory tests can detect deficiencies, mutations like Factor V Leiden, and antiphospholipid antibodies, aiding risk assessment for TE.
Area of Science:
- Genetics and Molecular Biology
- Hematology
- Clinical Pathology
Context:
- Thromboembolism (TE) poses a significant risk for recurrence.
- Identifying genetic and environmental risk factors is crucial for patient management.
- Laboratory investigations are essential for evaluating TE recurrence risk.
Purpose:
- To outline key genetic and acquired risk factors associated with thromboembolism (TE).
- To highlight the utility of laboratory investigations in assessing TE recurrence risk.
- To inform clinical practice regarding the evaluation of patients with a history of TE.
Summary:
- Genetic factors, including Factor V Leiden and prothrombin G20210A mutations, are prevalent in TE patients.
- Coagulation inhibitor deficiencies, increased Factor VIII, and hyperhomocysteinemia are also identified risk factors.
- Antiphospholipid antibodies represent another significant association with TE.
- Laboratory testing aids in identifying these risk factors to predict recurrence.
Impact:
- Enables targeted laboratory investigations for patients at risk of recurrent TE.
- Improves the accuracy of risk stratification for thromboembolic events.
- Facilitates personalized medicine approaches in managing patients with TE.